Three-dimensional skin model
AssigneeFraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
InventorsMichael Noll, Thomas Grave
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for cultivating dermal fibroblasts, methods for preparing in vitro dermis equivalents, methods for preparing three-dimensional in vitro skin equivalents, an in vitro dermis equivalent, a three-dimensional in vitro skin equivalent, and methods for determining the effect of a chemical substance or of an agent on human skin cells using the in vitro dermis equivalent and/or the in vitro skin equivalent.
Claims20
Method for multiplying dermal fibroblasts, wherein the dermal fibroblasts are cultivated embedded in a three-dimensional, gel-like biomatrix, containing at least 3 mg/ml of collagen in buffered, serum-containing cell culture medium, whereby the collagen solution used for the production of the biomatrix has a high content of non-denatured, native collagen.
Method for studying the function, morphology and/or differentiation status of dermal fibroblasts, wherein the dermal fibroblasts to be studied are introduced into a three-dimensional, gel-like biomatrix containing at least 3 mg/ml of collagen in buffered, serum-containing cell culture medium, whereby the collagen solution used for the production of the biomatrix has a high content of non-denatured, native collagen, are cultivated therein, and are tested simultaneously and/or subsequently.
Method for producing an in vitro dermis equivalent, wherein dermal fibroblasts are embedded into a three-dimensional, gel-like biomatrix containing at least 3 mg/ml of collagen in buffered, serum-containing cell culture medium, whereby the collagen solution used for the production of the biomatrix has a high content of non-denatured, native collagen, and are cultivated therein in such a way that an in vitro dermis equivalent is obtained.
Method for producing a three-dimensional in vitro skin equivalent, wherein dermal fibroblasts are embedded into a three-dimensional, gel-like biomatrix containing at least 3 mg/ml of collagen in buffered, serum-containing cell culture medium, whereby the collagen solution used for the production of the biomatrix has a high content of non-denatured, native collagen, and are subjected to an at least one-to two-day submerse culture therein, and wherein keratinocytes are then seeded in a cell culture medium on the biomatrix and are then further cultivated so that a three-dimensional in vitro skin equivalent is obtained.
Dependencies are inferred from the claim text.